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Because several related errors during the preparation of themanuscript, the description of in the “Network Analysis”
section led to confusion. Moreover, we encountered errors in
the assignments of low- and high-fat diet (LFD, HFD) and
ambiguities in the section termed “Integrating Transcriptomics,
Proteomics, and Metabolomics Data” that also might lead to
potential incomprehensiveness.
Importantly, the main results and conclusions are not
affected by the clarifying changes made here. We sincerely
apologize for these regrettable mistakes and for any confusion
this may have caused.
For better overview, we here provide the corrected errors in
the context of the affected text sections.
1. NETWORK ANALYSIS
Using our protein expression data sets, we analyzed protein
networks to infer and characterize hub proteins that may exert
major functions during HFD and drug treatment with RGZ.
Only the proteins which were down regulated in HFD and up
regulated in RGZ-HFD in WAT generated large networks
(Figure 5), in contrast to liver tissue. The KEGG pathway
affiliation of these networks was examined and revealed that the
networks belong to energy metabolism (e.g., OXPHOS, TCA
cycle, and branched chain amino acids (BCAA)). The network
similarity between LFD/HFD and RGZ-HFD/HFD in WAT
(Figure 5) shows that the drug treatment by RGZ puts the
HFD condition in part back to a LFD-like condition. This was
confirmed by a direct network comparison of LFD versus RGZ-
HFD, resulting in a neutralization of the TCA and OXPHOS
networks (Supporting Information, Figure 2).
To identify the main important proteins within the discussed
networks, we used the Cytoscape plug in “network analyzer”
and a robustness test to identify the hubs. The main hub
protein (in terms of centrality and robustness) in both
networks was succinate dehydrogenase iron−sulfur subunit
(SDHB; 2-fold down regulated due to HFD, 1.5-fold up
regulated due to RGZ treatment), part of the TCA cycle and
respiratory chain. Furthermore, succinyl-CoA ligase subunit
alpha (SUCLG1; 1.5 fold down regulated for HFD and 1.5 fold
up regulated for RGZ), catalyzing the ATP- or GTP-dependent
ligation of succinate and CoA to form succinyl-CoA was a main
hub (Table 2). This shows again the effectiveness of RGZ to
turn HFD WAT into a LFD-like condition.
2. LAST TWO PARAGRAPHS OF INTEGRATING
TRANSCRIPTOMICS, PROTEOMICS, AND
METABOLOMICS DATA SECTION
For a more detailed pathway analysis of transcripts, proteins,
and metabolites, we picked the citric acid cycle (TCA) as a
strongly regulated pathway between LFD/HFD condition in
WAT (Figure 7). More than half of the detected RNAs were at
least 1.5-fold up regulated in the LFD compared with the HFD
state, whereas all detected proteins in this pathway were not
significantly regulated on the basis of individual protein ratios,
although the whole protein pathway was significantly up
regulated (see Supporting Information, Figure 1B). Notably,
although RNA and protein levels were up regulated,
metabolites within the TCA cycle were down regulated, except
incoming acetyl-CoA, which was 2-fold up regulated. This
result shows fine-tuned regulations at the three investigated
interconnected biological levels: Up regulated levels of RNAs
or proteins do not necessarily mean that there are more
metabolites present, but may rather indicate compensatory
relative effects to regain metabolic homeostasis.
We further analyzed the valine, leucine, and isoleucine
degradation pathway in more detail between LFD/HFD
condition in WAT (Figure 8). We observed a significant up
regulation on the BCAA pathway level for RNA, protein, and
metabolite data sets in adipose tissue (Supporting Information,
Figure 1B). Notably, a recent study of morbidly obese subjects
with type 2 diabetes suggested that the reduction of BCAAs in
blood resulting from gastric bypass surgery may be associated
with improvement in blood sugar regulation.41 Our WAT data
indicate that increased amounts of BCAAs induce an increasing
expression of genes and proteins required for degradation of
BCAA, which might have an impact on levels of BCAAs in
blood. Furthermore, the up regulation of this pathway in LFD
compared to HFD could be a compensatory reaction, as this
amino acid breakdown generates acyl-CoA derivatives, which
can enter the TCA cycle.
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Figure 5. Network of down regulated proteins in (A) HFD and up regulated in (B) RGZ-HFD fat tissue, visualized by STRING software (version
9.1). (A) LFD/HFD ratios. (B) RGZ-HFD/HFD ratios. The top hub proteins are indicated according to Table 2. Proteins are colored according
their KEGG pathway affiliation: red = BCAA, yellow = TCA cycle, and green = OXPHOS.
Table 2. Network Analysis of Down Regulated HFD and Up Regulated RGZ-HFD Proteins in WAT To Determine the Main
Hubs in Terms of Robustness and Betweenness Centralitya
protein nodes average distance network diameter node degree betweenness centrality closeness centrality
network down LFD/HFD 165 4.49 12
SDHB 164 4.66 12 20 0.21 0.34
SUCLG1 163 4.81 12 21 0.12 0.34
NDUFS1 158 6.82 19 16 0.11 0.32
EHHADH 154 7.48 21 18 0.08 0.27
ACAA2 152 7.87 21 18 0.05 0.32
UQCRC2 148 9.16 24 28 0.06 0.33
network down RGZ/HFD 108 2.83 8
SUCLG1 107 2.98 8 21 0.27 0.52
UQCRC1 106 3.10 8 27 0.16 0.50
NDUFB5 105 3.38 9 23 0.06 0.48
SDHB 104 3.52 9 16 0.04 0.43
DLAT 102 4.05 11 12 0.05 0.38
HADHB 100 4.46 11 19 0.12 0.45
aNodes are connected proteins within a network; the average distance between nodes is calculated after removal of a node; the diameter of a
network is defined as the longest of all calculated shortest paths in a network. All three of these criteria are indicators of the network robustness and
resilience. Node degree is the number of connections between one node to others; the betweenness centrality is equal to the number of shortest
paths from all vertices to all others that pass through that node; closeness centrality is the distance metric between all nodes, defined by the length of
their shortest paths.
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